Daily summary: European equities higher on Brexit hopes

9:03 pm 23 December 2020

  • UK and the EU are close to reach a Brexit trade deal, officials say
  • Trump could veto the coronavirus aid bill.
  • New South African Covid-19 strain identified in the UK
  • US Crude stocks all less than expected
  • France reopens border with U.K. 

European indices finished today’s session higher following the news that the Brexit trade deal can be reached today and as France reopened its borders with Britain with people required to show proof of a negative Covid-19 test taken within the previous 72 hours. Also other countries have also severed transport links with the U.K., but the French border is of particular importance as it covers the Channel Tunnel, a vital artery for trade within the continent. Meantime Britain and the European Union are close to clinching a Brexit trade deal, diplomats said on Wednesday, however, this has not been officially confirmed. Bloomberg reported that the outline of a post-Brexit trade agreement has been reached, citing officials familiar with the matter although EU-UK trade talks are still in their “final stages” according to a source from Reuters. However, EU ambassadors meeting has been convened for tomorrow to be briefed on Brexit negotiations. This may be a sign that the Brexit deal is virtually done. Meanwhile a second new variant of the COVID-19 has been detected in the UK having first been discovered in South Africa. The government is now set to implement travel restrictions on those entering the nation from South Africa. DAX 30 rose more than 1%, CAC advanced 1.1% and FTSE100 gained 0.7%.

US stocks also moved higher even after President Donald Trump expressed concerns about the new Covid-19 relief package calling it an unsuitable “disgrace” and urged lawmakers to make a number of changes to the measure, including raising checks to $2,000 from $600. Moods in the markets improved after jobless claims unexpectedly fell last week,  however they still remained at elevated levels due to restrictions to curb the spread of new COVID-19 infections. Meantime Pfizer Inc (PFE.US) reached a deal with the US government to buy an additional 100 million doses of the company’s Covid-19 vaccine.

US crude futures are trading 2.40% higher at $ 48.15 a barrel, while Brent contract rose 2.3% to $ 51.26. US crude oil inventories fell by 0.562 million barrels in the week ended December 18th, following a 3.135 million decline in the previous week and compared with analysts’ estimates of a 3.186 million decline, according to the EIA Petroleum Status Report. Gasoline inventories fell 1.12 million barrels last week the EIA said, compared with expectations for a 1.2 million-barrel build. Yesterday API data had shown a surprise crude oil inventory build in the US. Elsewhere, gold futures jumped 0.69% to $ 1,872.00 /oz, while silver is trading 1.9% higher at $25.60/oz.

WTI crude futures (OIL.WTI) rose sharply after publication of today's EIA report. Price broke above both 50 SMA (green line) and 200 SMA (red line) and reached resistance at $48.00 level. If buyers will manage to uphold momentum, the upward move could be extended to the resistance at $49.36. On the other hand, breaking below the aforementioned $48.00 level may trigger a bigger downward correction. Source: xStation5.

The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.

Share:
Back

Join over 1 600 000 XTB Group Clients from around the world.